Complementary and Alternative Medicine

Industry Calls on FDA to Adopt National Standards on Ephedra

Published in Medical Letter on the CDC and FDA, November 12th, 2000

Four dietary supplement associations, representing the majority of manufacturers and distributors of supplements containing ephedra, are calling on the U.S. Food and Drug Administration (FDA) to adopt a national standard for the formulation, labeling, and marketing of ephedra products.

The standard, detailed in a Citizen Petition filed with FDA, has already been adopted by industry and several states. This initiative is consistent with the overwhelming data in support of the safety of dietary supplements containing ephedra.

"Our associations have worked closely together to develop responsible guidelines for supplements that contain Ephedra...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2000-11-12)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry